First extensive immune profiling of sarcomas shows some types may be susceptible to immunotherapy; Fred Hutch hosts first-of-its-kind regional conference for science communicators; and Pathway that regulates organ size may also underlie tumors’ resistance to certain chemotherapy drugs.
Early detection, better treatments contributed to 23 percent decline in two decades, report shows
Jan. 7, 2016
| By Bill Briggs / Fred Hutch News Service
Heightened health habits and better medicine are curbing cancer’s killing force in America as the nation’s death rate from all malignancies dropped 23 percent during the past two decades, a new analysis shows. But declining rates of heart disease have made cancer the top cause of death in 21 states.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.